The Chemours Firm (NYSE:CC) Shares Acquired by Redwood Funding Administration LLC

Redwood Funding Administration LLC raised its holdings in shares of The Chemours Firm (NYSE:CC – Get Ranking) by 32.9% in the course of the third quarter, in line with the corporate in its most up-to-date disclosure with the Securities and Trade Fee. The institutional investor owned 50,721 shares of the specialty chemical substances firm’s inventory after buying a further 12,565 shares in the course of the interval. Redwood Funding Administration LLC’s holdings in Chemours had been price $1,250,000 on the finish of the newest quarter.

→ Purchase THIS inventory earlier than Taiwan is attacked (From Behind the Markets)

Numerous different giant traders have additionally made modifications to their positions in CC. Raymond James & Associates elevated its place in shares of Chemours by 31.0% in the course of the first quarter. Raymond James & Associates now owns 135,617 shares of the specialty chemical substances firm’s inventory price $4,269,000 after buying a further 32,121 shares within the final quarter. Cetera Advisor Networks LLC elevated its place in shares of Chemours by 21.3% in the course of the first quarter. Cetera Advisor Networks LLC now owns 9,636 shares of the specialty chemical substances firm’s inventory price $303,000 after buying a further 1,695 shares within the final quarter. Financial institution of Montreal Can elevated its place in shares of Chemours by 36.4% in the course of the first quarter. Financial institution of Montreal Can now owns 73,197 shares of the specialty chemical substances firm’s inventory price $2,361,000 after buying a further 19,552 shares within the final quarter. D.A. Davidson & CO. acquired a brand new place in shares of Chemours within the 1st quarter valued at $208,000. Lastly, MetLife Funding Administration LLC elevated its place in shares of Chemours by 35.7% within the 1st quarter. MetLife Funding Administration LLC now owns 107,133 shares of the specialty chemical substances firm’s inventory valued at $3,373,000 after buying a further 28,160 shares in the course of the interval. 71.89% of the inventory is owned by institutional traders and hedge funds.

Chemours Worth Efficiency

NYSE:CC opened at $33.75 on Friday. The agency’s fifty day shifting common is $33.25 and its two-hundred day shifting common is $31.90. The corporate has a debt-to-equity ratio of three.24, a fast ratio of 0.96 and a present ratio of 1.70. The Chemours Firm has a one yr low of $22.56 and a one yr excessive of $44.95. The agency has a market cap of $5.01 billion, a price-to-earnings ratio of 9.45, a PEG ratio of 1.29 and a beta of 1.88.

Chemours Broadcasts Dividend

The corporate additionally not too long ago introduced a quarterly dividend, which can be paid on Wednesday, March fifteenth. Stockholders of report on Friday, February twenty fourth can be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of two.96%. The ex-dividend date of this dividend is Thursday, February twenty third. Chemours’s payout ratio is at the moment 28.01%.

Wall Road Analyst Weigh In

A number of equities analysts not too long ago issued stories on CC shares. UBS Group raised Chemours from a “impartial” ranking to a “purchase” ranking and upped their goal value for the corporate from $31.00 to $43.00 in a analysis report on Tuesday, January twenty fourth. Citigroup upped their goal value on Chemours from $33.00 to $35.00 and gave the corporate a “impartial” ranking in a analysis report on Monday, February thirteenth. Royal Financial institution of Canada upped their goal value on Chemours from $33.00 to $36.00 and gave the corporate a “sector carry out” ranking in a analysis report on Monday, February thirteenth. StockNews.com downgraded Chemours from a “purchase” ranking to a “maintain” ranking in a analysis report on Monday, February thirteenth. Lastly, Barclays upped their goal value on Chemours from $30.00 to $34.00 in a analysis report on Tuesday, November 1st. One analysis analyst has rated the inventory with a promote ranking, seven have assigned a maintain ranking and three have assigned a purchase ranking to the inventory. Based mostly on information from MarketBeat.com, the corporate at the moment has a consensus ranking of “Maintain” and a median value goal of $36.33.

About Chemours

(Get Ranking)

The Chemours Co is a holding firm, which engages within the provision of efficiency chemical substances. The agency delivers options, which embody a variety of business and chemical merchandise for markets together with coatings, plastics, refrigeration and air con, transportation, semiconductor and client electronics, and basic industrial.

Featured Articles

This instantaneous information alert was generated by narrative science expertise and monetary information from MarketBeat with the intention to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial group previous to publication. Please ship any questions or feedback about this story to [email protected].

Earlier than you think about Chemours, you will need to hear this.

MarketBeat retains monitor of Wall Road’s top-rated and greatest performing analysis analysts and the shares they suggest to their purchasers every day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Chemours wasn’t on the listing.

Whereas Chemours at the moment has a “Maintain” ranking amongst analysts, top-rated analysts imagine these 5 shares are higher buys.

View The 5 Shares Right here